Transaction DateRecipientSharesTypePriceValue
1st December 2020Dan Puckett200Open or private sale$95.41$19,082.00
1st December 2020Dan Puckett900Open or private sale$94.59$85,131.00
1st December 2020Dan Puckett200Open or private sale$96.43$19,286.00
1st December 2020Dan Puckett700Open or private sale$93.17$65,219.00
1st December 2020Dan Puckett1,659Exercise of derivative$17.00$28,203.00
1st December 2020Dan Puckett341Exercise of derivative$3.42$1,164.86
23rd November 2020Antoine Papiernik16,955Open or private sale$101.00$1,712,455.00
23rd November 2020Antoine Papiernik28,500Open or private sale$99.02$2,822,070.00
20th November 2020Antoine Papiernik1,500Open or private sale$99.03$148,545.00
20th November 2020Antoine Papiernik21,900Open or private sale$97.03$2,124,957.00
Shockwave Medical
Shockwave Medical logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease.


Ticker: SWAV
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1642545
Employees: 284
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals